| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/14/2013 | US20130039849 Adenocarcinoma specific antibody sam-6, and uses thereof |
| 02/14/2013 | US20130039848 Fluorescent silica-based nanoparticles |
| 02/14/2013 | CA2844855A1 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
| 02/14/2013 | CA2844852A1 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
| 02/14/2013 | CA2844588A1 Pyrido-pyrimidine derivatives |
| 02/14/2013 | CA2844525A1 Cyclopropaneamine compound |
| 02/14/2013 | CA2844507A1 Jak pi3k/mtor combination therapy |
| 02/14/2013 | CA2844469A1 N- (benzimimdazol-2-yl) -cyclopropane carboxamides as lysophosphatidic acid antagonists |
| 02/14/2013 | CA2844283A1 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer |
| 02/14/2013 | CA2842971A1 Improved methods and compositions for modulation of olfml3 mediated angiogenesis |
| 02/13/2013 | EP2557155A1 Metal salen complex derivative and process for production thereof |
| 02/13/2013 | EP2557080A1 Method for identifying pI3-kinase antagonists |
| 02/13/2013 | EP2556840A2 Composition for increasing trail sensitivity, containing an inhibitor for inhibiting the expression or activity of tip41 which is a trail sensitizer target gene |
| 02/13/2013 | EP2556379A1 New diagnostic and therapeutic target |
| 02/13/2013 | EP2556082A2 Substituted androst-4-ene diones |
| 02/13/2013 | EP2556081A2 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation |
| 02/13/2013 | EP2556072A1 2-phenyl benzothiazole linked imidazole compounds as potential anticancer agents and process for the preparation thereof |
| 02/13/2013 | EP2556071A1 Kinase inhibitors and method of treating cancer with same |
| 02/13/2013 | EP2556070A1 Synthesis of chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'- indolin]-2'-ones |
| 02/13/2013 | EP2556066A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 02/13/2013 | EP2556065A1 Pyrazole p38 map kinase inhibitors |
| 02/13/2013 | EP2556055A2 Ship inhibitors and uses thereof |
| 02/13/2013 | EP2555802A1 Methods and compositions for enhanced delivery of compounds |
| 02/13/2013 | EP2555800A1 Enhancement of radiation therapy by targeted high-z nanoparticles |
| 02/13/2013 | EP2555782A1 Compositions and methods for providing hematopoietic function without hla matching |
| 02/13/2013 | EP2555781A1 Compositions and methods for providing hematopoietic function |
| 02/13/2013 | EP2555627A1 Methods of treating cancer |
| 02/13/2013 | CN102933658A Local delivery of drugs from self assembled coatings |
| 02/13/2013 | CN102933603A Methods for treating pancreatic cancer |
| 02/13/2013 | CN102933584A Pyrrolopyrazinone inhibitors of kinases |
| 02/13/2013 | CN102933573A Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof |
| 02/13/2013 | CN102933572A Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 02/13/2013 | CN102933571A Phthalazin-(2h)-one inhibitors of kinases |
| 02/13/2013 | CN102933561A Pharmaceutically active disubstituted triazine derivatives |
| 02/13/2013 | CN102933560A 4,6-dibenzamido-2-methyl-pyridine derivatives and applications to cancer treatment |
| 02/13/2013 | CN102933559A Optically active dibenzylamine derivative, and manufacturing method for same |
| 02/13/2013 | CN102933558A Reverse amide compounds as protein deacetylase inhibitor and methods of use thereof |
| 02/13/2013 | CN102933551A Hydrated crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| 02/13/2013 | CN102933548A Carboxamide compounds and their use as calpain inhibitors |
| 02/13/2013 | CN102933258A Radiotherapy combined with hypoxic cell sensitizers |
| 02/13/2013 | CN102933236A Pyrrolobenzodiazepines and conjugates thereof |
| 02/13/2013 | CN102933216A Anti-brain-tumor drug |
| 02/13/2013 | CN102933213A Radiation sensitiser compositions |
| 02/13/2013 | CN102925564A Use and expression vector of gene C2orf40 in preparation of medicines for preventing, diagnosing or treating tumor of breast and diagnosis medicine thereof |
| 02/13/2013 | CN102925472A Recombinant expression of actinoporins proteins |
| 02/13/2013 | CN102925443A Targeting silencing MyoX sequence preparation and vector construction of sequence |
| 02/13/2013 | CN102925412A Method for preparing tumor specific antigen sensitized DC |
| 02/13/2013 | CN102925372A Marine fungus rhodotorula minuta and application thereof in preparing anti-tumor medicines |
| 02/13/2013 | CN102925321A Health wine |
| 02/13/2013 | CN102925291A Variable pressure distillation method for extracting pythoncidere and essential oil from Chamaecyparis plants |
| 02/13/2013 | CN102924627A Preparation method of low-anticoagulant heparin with anti-tumor activity |
| 02/13/2013 | CN102924619A Agaricus blazei murill extract and preparation method thereof |
| 02/13/2013 | CN102924606A Antitumor and thrombolytic double-effect chimeric protein of targeting tumor cell, preparation method and application thereof |
| 02/13/2013 | CN102924604A Recombined vessel endothelium growth factor receptor, encoding genes thereof and application |
| 02/13/2013 | CN102924600A Death receptor-5 agitated polyvalent antibody and application thereof in preparation of anti-tumor medicines |
| 02/13/2013 | CN102924598A Anti-alphavbeta6 antibodies |
| 02/13/2013 | CN102924579A Polypeptide with function of increasing activities of human NK (Natural Killer) and NKT (Natural Killer T) cells for killing tumor cells and application of polypeptide |
| 02/13/2013 | CN102924578A Anti-tumor polypeptide, preparation method and anti-tumor applications thereof |
| 02/13/2013 | CN102924558A Betulinic acid esters derivative and preparation method and use of betulinic acid esters derivative |
| 02/13/2013 | CN102924557A Triterpene compounds, preparation methods and applications thereof |
| 02/13/2013 | CN102924550A Decitabine 5'-O-amino-acid ester prodrug and preparation method thereof |
| 02/13/2013 | CN102924528A Anti-tumor bivalent platinum complex and preparation method for complex and ligand of complex |
| 02/13/2013 | CN102924527A Ru(II) complex with anticancer activity and preparation method of complex |
| 02/13/2013 | CN102924525A Synthesis method for novel ruthenium (II) polypyridyl complex |
| 02/13/2013 | CN102924507A An anti-tumor compound and its preparation method, application, and pharmaceutical compositions |
| 02/13/2013 | CN102924488A Structure, preparation method and purpose of silver-containing pyrazine Schiff base complex |
| 02/13/2013 | CN102924479A Semisynthetic method of staurosporine derivative |
| 02/13/2013 | CN102924465A Chiral furanone alpha, beta-unsaturation cyclic ketone, preparation method of chiral furanone alpha, beta-unsaturation cyclic ketone and application of chiral furanone alpha, beta-unsaturation cyclic ketone |
| 02/13/2013 | CN102924458A 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 02/13/2013 | CN102924456A Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives |
| 02/13/2013 | CN102924450A 6-(5-pyridyl)-1,2,4-triazolopyridine compound, and preparation method and application thereof |
| 02/13/2013 | CN102924446A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
| 02/13/2013 | CN102924445A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
| 02/13/2013 | CN102924444A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
| 02/13/2013 | CN102924441A N-(4-(4-(3-fluorophenyl)piperazin-1-yl)pyrimidin-2-yl)-amide or salts thereof, preparation method and applications |
| 02/13/2013 | CN102924437A 3-piperazine-4-indol maleimide compound and preparation and application thereof |
| 02/13/2013 | CN102924429A 1,2-naphthaquinone derivatives and preparation method thereof |
| 02/13/2013 | CN102924426A 3,4-methylenedioxyphenethylamine hydrochloride-5-chlorosalicylaldehyde, synthesis method and application of 3,4-methylenedioxyphenethylamine hydrochloride-5-chlorosalicylaldehyde |
| 02/13/2013 | CN102924425A Homopiperony lamine 3-methyl-5-chlorine salicylide and synthesis method and application thereof |
| 02/13/2013 | CN102924421A Preparation method and application of compound having tyrosinase inhibitory activity |
| 02/13/2013 | CN102924400A N-acyl-4-tertiary butyl-5-benzyl thiazole-2-amine as well as preparation method and application thereof |
| 02/13/2013 | CN102924387A 4-(3-chloro-4-methoxyanilino)-6-(3,4-substituted phenyl)quinazoline and salts thereof, preparation method and applications |
| 02/13/2013 | CN102924372A Synthesis and application of antineoplastic 2-amino-3-cyano pyridine |
| 02/13/2013 | CN102924356A Preparation method for 2-substituted benzldehyde shrank hydrazine-sulfo-benzyl formate schiff base zinc and nickel complex |
| 02/13/2013 | CN102924355A 2-substituted benzaldehyde s-benzyldithiocarbazate Schiff base zinc and nickel coordination compound and application thereof |
| 02/13/2013 | CN102921022A Drug-loaded nanoparticle with nuclide imaging, fluorescence imaging and MRI functions, and preparation method and application thereof |
| 02/13/2013 | CN102921020A Gene drug for combined treatment on tumors, and use thereof |
| 02/13/2013 | CN102921019A Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells |
| 02/13/2013 | CN102921017A Nano hybrid of cytarabine/layered double-metal hydroxides and preparation process of nano hybrid |
| 02/13/2013 | CN102921016A Norcantharidin/layered double hydroxide nano hybrid and preparation method thereof |
| 02/13/2013 | CN102921015A Hyaluronic acid nanometer selenium and preparation method as well as application thereof |
| 02/13/2013 | CN102921014A Biocompatible nano composite drug carrier with synergistic anti-tumor effect, drug with synergistic anti-tumor effect and preparation methods of biocompatible nano composite drug carrier and drug |
| 02/13/2013 | CN102921006A Application of tungsten oxide matrix nanometer materials in preparation of near-infrared light heat treatment drugs |
| 02/13/2013 | CN102921005A Cu2S-ZnS-Cu2S nano heterojunction light absorber and synthesis method thereof |
| 02/13/2013 | CN102921003A Stabilized immune modulatory RNA (SIMRA) compounds |
| 02/13/2013 | CN102921000A Application of acetylcholinesterase as nuclease |
| 02/13/2013 | CN102920977A Traditional Chinese medicine composition for treating liver cancer |
| 02/13/2013 | CN102920976A External traditional Chinese medicine composition for preventing and treating liver cancer pain |
| 02/13/2013 | CN102920965A Traditional Chinese medicine water-bindered pill for treating advanced lung cancer |
| 02/13/2013 | CN102920951A Traditional Chinese medicine for treating gastric cancer |